Other studies have shown that NSG mouse-repopulating AML stem cells reside in both the CD34+/CD38+ and the CD34+/CD38− fraction of AML cells, or even in CD34− subfractions of the clone [22,23]. The gene discussed is CD38; the disease is acute myeloid leukemia.